- Management of primary and secondary tumours of the central nervous system, eyes and pediatric malignancies
- Methods of optimizing radiation treatment for malignancies of the brain by conformal radiation therapy and/or sensitizing agents
- Determining the value of stereotactically directed radiation therapy for primary tumours of the eye
- Investigating predictive values of MRI spectroscopy/PET changes relative to recurrence patterns of malignant glioma in brain
J Matern Fetal Neonatal Med. 2018 Dec 18;:1-311
Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.
Neuro Oncol. 2018 Nov 19;:
Clin Oncol (R Coll Radiol). 2018 Oct 29;:
Outcomes following SRS for small- to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose.
Neuro Oncol. 2018 Sep 28;:
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges.
Neuro Oncol. 2018 Sep 05;:
Significance of treatment response when managing patients with primary central nervous system lymphoma.
Leuk Lymphoma. 2018 Jul 03;:1-9
Pediatr Blood Cancer. 2018 Jan 25;:
Cochrane Database Syst Rev. 2018 Jan 25;1:CD003869
Trigeminal nerve integrated dose and pain outcome after gamma knife radiosurgery for trigeminal neuralgia.
J Radiosurg SBRT. 2012;1(4):295-301
Can J Neurol Sci. 2017 Dec 18;:1-7
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
Staff Radiation Oncologist, Princess Margaret Cancer Centre
Associate Director, Gerry and Nancy Pencer Brain Tumour Centre, Princess Margaret Cancer Centre